| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,756 |
24,208 |
$1.55M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,697 |
11,840 |
$911K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13,458 |
12,376 |
$300K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,927 |
3,819 |
$254K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,121 |
3,043 |
$206K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,731 |
2,547 |
$166K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,597 |
4,231 |
$153K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,481 |
4,429 |
$134K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,375 |
6,723 |
$101K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,365 |
1,335 |
$90K |
| 90658 |
|
1,824 |
1,770 |
$28K |
| 90651 |
|
406 |
392 |
$18K |
| 90670 |
|
360 |
350 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,409 |
810 |
$11K |
| 90716 |
|
233 |
221 |
$6K |
| 99401 |
|
444 |
442 |
$6K |
| 90713 |
|
1,165 |
1,101 |
$6K |
| 90677 |
|
111 |
105 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
993 |
866 |
$5K |
| 90700 |
|
1,043 |
982 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
84 |
84 |
$4K |
| 90734 |
|
196 |
193 |
$4K |
| 99381 |
|
44 |
44 |
$3K |
| 99215 |
Prolong outpt/office vis |
34 |
34 |
$3K |
| 90707 |
|
204 |
187 |
$3K |
| 90656 |
|
144 |
144 |
$2K |
| 86580 |
|
485 |
482 |
$2K |
| 90657 |
|
497 |
479 |
$1K |
| 90620 |
|
28 |
27 |
$837.32 |
| 90633 |
|
151 |
146 |
$728.47 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
12 |
12 |
$680.47 |
| 90647 |
|
353 |
329 |
$604.51 |
| 90715 |
|
75 |
75 |
$501.42 |
| 83655 |
|
89 |
87 |
$434.12 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
28 |
28 |
$422.36 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
31 |
30 |
$370.26 |
| 90744 |
|
133 |
101 |
$303.57 |
| 81002 |
|
212 |
202 |
$186.62 |
| 90461 |
|
12 |
12 |
$182.10 |
| 97802 |
|
3,401 |
3,341 |
$178.32 |
| 81025 |
|
51 |
49 |
$145.37 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16 |
13 |
$136.08 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
101 |
95 |
$101.00 |
| 90680 |
|
14 |
12 |
$88.64 |
| 81000 |
|
40 |
40 |
$53.47 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
35 |
31 |
$39.32 |
| 36416 |
|
121 |
119 |
$0.00 |